期刊文献+

不同剂量环磷酰胺建立小鼠少精子症模型

Establishment of oligosperm model by different doses of cyclophosphamide in mice
原文传递
导出
摘要 目的探讨用环磷酰胺建立小鼠少精子症动物模型的最佳诱导剂量。方法选择雄性小鼠120只随机分4组,连续5d分别以生理盐水(对照组),不同剂量的环磷酰胺(每日100、80、60mg/kg体重)于腹腔内注射,在不同时段分批处死各组小鼠,检测血清T、LH水平,一侧睾丸匀浆后测定(丙二醛)MDA含量,另一侧睾丸切片苏木素-伊红(HE)染色进行生精小管上皮层次和间质细胞计数。结果剂量每日为80mg/kg体重小鼠成模后死亡率为16.7%,血清T[30d:(1.38±0.31);45d:(1.15±0.26)]及T/LH比值[30d:(0.163±0.014);45d:(0.127±0.023)]于诱导后第30天出现显著下降(P均〈0.05),而诱导后睾丸组织内MDA含量[15d:(2.70±0.41);30d(2.71±0.36);45d:(2.67±0.43)]维持高水平(P均〈0.05),生精上皮层次[15d:(4.75±0.82);30d:(3.60±0.49);45d:(3.74±0.43)]和间质细胞[15d:(9.65±0.75);30d:(14.05±0.67);45d:(8.49±0.72)]均显著减少(P均〈0.01)并稳定于低水平,模型稳定,死亡率适当;每日60mg/kg体重组小鼠血清T及T/LH比值于不同时段并未出现明显变化(P〉0.05),且睾丸组织内MDA含量、生精上皮层次和间质细胞计数在30d后有所恢复,模型不稳定;每日100mg,/kg体重组死亡率为30.0%,死亡率过高。结论腹腔内注射环磷酰胺建立小鼠少精子症模型的最佳剂量为每日80mg/kg体重。 Objective To explore the optimal dosage of cyclophosphamide for inducing oligosperm in mouse model. Methods One hundred and twenty experimental male mice were randomly divided into 4 groups,which were respectively treated by intraperitoneal injection of normal saline (control) and different doses of cyclophosphamide ( 100,80,60 mg/kg, day) continuously for 5 days. The mice were killed in batches at different time points. The serum testosterone (T) and luteotrophic hormone (LH) levels were measured. A suspension was made from the testis of one side for malondialdehyde (MDA) level analysis,while the testis of other side was sliced up and stained by HE method to detect the count of Leydig cells and the layers of spermatogenetic epithelia. Results The mortality rate of mice in 80 mg/kg, day cyelophosphamide group was 16.7% , and T level [ at 30th day : ( 1.38±0.31 ) ;45th day : ( 1.15 ±0.26 ) ] and T/LH ratio [ at 30th day: (0. 163 ±0. 014) ;45th day: (0. 127±0. 023) ] were significantly decreased (all P 〈 0.05 ) at 30th day after induction;The concentration of MDA [ at 15th day: (2.70±0.41) ;30th day:(2.710.36) ;45th day: (2.67 ±0.43) ] was maintained at a high level (all P 〈0.05) during the 45 days ; Number of Leydig' s ceils [ at 15th day : ( 9.65±0.75 ) ; 30th day : ( 14.05± 0.67 ) ; 45th day : ( 8.49±072) ] and layers of spermatogenetic epithelia [ at 15th day: (4.75 ±0.82) ;30th day : ( 3.60 ± 0.49 ) ;45th day : ( 3.74 ± 0.43 ) ] were significantly decreased ( all P 〈 0.01 ) and stabilized in a low level. The induced model was stable and the mortality rate was acceptable. In the 60 mg/kg, day eyclophosphamide group, the T level and T/LH ratio had no significant change (P 〉 0.05 ), and the concentration of MDA, number of Leydig' s cell and layers of spermatogenetic epithelia recovered at 30th day after induction. The induced model was unstable. The mortality rate in 100 mg/kg, day cyclophosphamide group was 30% and unacceptable. Conclusion The optimal dosage of eyclophosphamide for inducing oligo- sperm in mouse model was 80 mg/kg, day.
作者 郭晓 程惠平
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2008年第10期1339-1341,共3页 Chinese Journal of Experimental Surgery
关键词 少精子症 模型 动物 环磷酰胺 Oligo sperm Model,animal Cyclophosphamide
  • 相关文献

参考文献5

二级参考文献31

  • 1沈国球,鲁功成,潘铁军,肖亚军.环磷酰胺诱导少精子/无精子症大鼠模型所致睾丸、附睾IGF-I的变化[J].中华男科学杂志,2005,11(9):664-666. 被引量:16
  • 2Meng X,Lindahl M,Hyvonen ME,et al.Regulation of cell fate decision of undifferentiated spermatogonia by GDNF [ J ].Science,2000,287(5457):1489-1493.
  • 3McLachlan RI,ODonnell L,Meachem SJ,et al.Hormonal regulation of spermatogenesis in primates and man:insights for development of the male contraceptive [ J ].J Androl,2002,23(2):149-162.
  • 4Themmen APN,Huhtaniemi IT.Mutations of gonadotropins and gonadotropin receptors:elucidating the physiology and pathophysiology of pituitary-gonadal function [ J ].Endoor Rev,2000,21(5):551-583.
  • 5Layman LC.Mutations in the follicle-stimulating hormone-beta(FSH beta)and FSH receptor genes in mice and humans[ J].Semin Reprod Med,2000,18(1):5-10.
  • 6Ramaswamy S,Plant TM.Operation of the follicle-stimulating hormone(FSH)-inhibin B feedback loop in the control of primate spermatogenesis[ J ].Mol Cell Endocrinol,2001,180(1-2):93-101.
  • 7Kinniburgh D,Anderson RA,Baird DT.Suppression of spermatogenesis with desogestrel and testosterone pellets is not enhanced by addition of finasteride[ J].J Androl,2001,22(1):88-95.
  • 8葛秦生主编.临床生殖内分泌学--男性与女性[M].北京:科学技术文献出版社,2001.762-800.
  • 9Wang C,Swerdloff RS.Male contraception [ J ].Best Pract Res Clin Obstet Gynaecol,2002,16(2):193-203.
  • 10Plant TM,Marshall GR.The functional significance of FSH in spermatogenesis and the control of its secretion in male primates [J].Endocr Rev,2001,22(6):764-786.

共引文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部